Exagen Inc. XGN Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s common stock, par value (in dollars per share)?
- Exagen Inc. (XGN) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Exagen Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Exagen Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Exagen Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Exagen Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.